Skip to content
Stop using now Drug recall · FDA · Published September 27, 2017

United Pharmacy Recalls Glutamine, Arginine and Carnitine Injection Vials

United Pharmacy recalls 268 vials of Glutamine, Arginine and Carnitine injection due to CGMP deviations. Check your lot numbers for safety.

🇺🇸 FDA recall #D-0008-2018DrugUnited Pharmacy ›
Take action

Contact the company

Recalling firmUnited Pharmacy3951 Haverhill Rd N · West Palm Beach, FL 33417-8154
✎ GovInfoNow plain-language explainer

What happened, in plain English

United Pharmacy is recalling a compounded injectable medication containing glutamine, arginine, and carnitine because FDA analysis found it did not contain the required glutamine and contained two unknown impurities. The recall affects 268 multi-dose vials distributed nationwide. No specific remedy or return instructions are currently listed in the record. Read more at govinfonow.com/recall/41162-united-pharmacy-recalls-glutamine-arginine-and-carnitine-injection-vials.

Source Summary by GovInfoNow · govinfonow.com/recall/41162-united-pharmacy-recalls-glutamine-arginine-and-carnitine-injection-vials · Updated October 11, 2026 · FDA enforcement record: FDA #D-0008-2018

Cite this page

“United Pharmacy Recalls Glutamine, Arginine and Carnitine Injection Vials.” GovInfoNow, updated October 11, 2026. https://govinfonow.com/recall/41162-united-pharmacy-recalls-glutamine-arginine-and-carnitine-injection-vials. Based on FDA recall #D-0008-2018 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0008-2018%22&limit=1).

Why it’s dangerous

The medication failed to contain glutamine, which is a critical component for its intended therapeutic effect. Additionally, the presence of two unknown impurities poses an unpredictable health risk to patients who may have already used the vials.

Who’s affected

Patients who received this compounded injection from United Pharmacy in West Palm Beach, FL, between the production dates of November 10, 2017, and January 14, 2018. Individuals with these specific lot numbers are at risk of receiving a product that lacks essential ingredients and contains unknown impurities.

How to tell if you have this one

Look for multi-dose vials labeled 'Glutamine, Arginine and Carnitine, 10/100/200mg/mL, 30 mL' manufactured by United Pharmacy. Check the lot numbers on the packaging: GAC-12 with a use-by date of 11/10/17, or GAC-13 with a use-by date of 01/14/18.

  • Brand
    United Pharmacy
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Stop using the medication

    Do not administer any remaining vials from lots GAC-12 or GAC-13 due to the risk of unknown impurities and missing ingredients.

  2. Contact your healthcare provider

    Speak with the doctor who prescribed the medication to discuss alternative treatments or further guidance regarding potential exposure.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 6 months after the firm started it.

1. Firm started the recall: Sep 27, 201712. FDA classified it Class II: Oct 10, 201723. Published in FDA’s Enforcement Report: Oct 18, 201734. FDA terminated the recall: Mar 29, 2018420172018
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0008-2018 (September 27, 2017) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0008-2018 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 11, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA